<SEC-DOCUMENT>0001193125-19-104225-index.html : 20190411 <SEC-HEADER>0001193125-19-104225.hdr.sgml : 20190411 <ACCEPTANCE-DATETIME>20190411210947 ACCESSION NUMBER: 0001193125-19-104225 CONFORMED SUBMISSION TYPE: S-1MEF PUBLIC DOCUMENT COUNT: 4 <REFERENCE-462B>333-230783 FILED AS OF DATE: 20190411 DATE AS OF CHANGE: 20190411 EFFECTIVENESS DATE: 20190411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1MEF SEC ACT: 1933 Act SEC FILE NUMBER: 333-230820 FILM NUMBER: 19744824 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 </SEC-HEADER> <DOCUMENT> <TYPE>S-1MEF <SEQUENCE>1 <FILENAME>d735405ds1mef.htm <DESCRIPTION>S-1MEF <TEXT> Document 1 - file: d735405ds1mef.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d735405dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d735405dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>d735405dex231.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: d735405dex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>4 <FILENAME>g735405g92t83.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 4 - file: g735405g92t83.jpg
</DOCUMENT> </SEC-DOCUMENT>